Surgical Case Reports (Jun 2022)

A case of strongly suspected Lynch syndrome with colorectal neuroendocrine carcinoma

  • Naoya Kobayashi,
  • Hiroshi Yoshida,
  • Shinya Kawaguchi,
  • Satoru Shiraso,
  • Noriko Nemoto,
  • Nanako Fujikawa,
  • Yoichi Haji,
  • Emiko Kono,
  • Shoji Kokubo,
  • Kazuhiko Tsukuda,
  • Shigeyuki Asano,
  • Fumiaki Shinya

DOI
https://doi.org/10.1186/s40792-022-01471-0
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Neuroendocrine cell carcinomas (NEC) of the colon and rectum are uncommon, representing ~ 0.1% of all colorectal carcinomas. They are associated with a much worse prognosis compared to adenocarcinoma of the colon and rectum, as death occurs in approximately half of all patients within 1 year. Lynch syndrome (LS) is the most common cause of inherited colorectal cancer, accounting for 2–4% of newly diagnosed colorectal cancer cases. This case is extremely rare which was strongly suspected LS as the background, and NEC as the histological type of colorectal cancer. Case presentation The patient was a 44-year-old man presenting with vomiting as the main complaint. He had undergone ileocecal resection for cecal cancer at age 29. The diagnosis was obstructive descending colorectal cancer, and colonoscopy revealed tumors in the rectum and sigmoid colon in addition. Due to multiple occurrences of colorectal cancer and its prevalence in the patient’s family, LS was suspected. The operation which was a subtotal proctocolectomy was performed. Pathological analysis revealed complete curative resection and the descending colon cancer of the obstructed portion was at the most advanced pathological Stage IIIC in UICC TNM classification, and the tissue type was a NEC. The Ki-67 index was 70%. The results of the microsatellite instability (MSI) test showed high-frequency MSI. The BRAF V600E variant was negative. The immunoexpression of MLH1 was positive, MSH2 was negative, PMS2 was positive, and MSH6 was negative. Conclusions Extended surgery is recommended for incipient colorectal cancer in LS cases in order to reliably reduce the risk of developing metachronous colorectal cancer. The survival outcome of surgery alone on digestive tract NECs, even locoregional lesions that are completely resection, is extremely poor. It is currently unclear if digestive tract NECs develop more readily in patients with LS. The accumulation of additional cases is necessary.

Keywords